StockData
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ

BriaCell Therapeutics Corp.

Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 9, 2026
$3.38−0.02 (-0.59%)

Close on Oct 19, 2026

Market cap
$24.51M
P/E (TTM)
–
Dividend yield
–

BriaCell Therapeutics statistics

Financials through Apr 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureBriaCell TherapeuticsIndustry median
Market Cap$29.41M$166.30M
Enterprise Value$5.95M$88.19M

Income (trailing twelve months)

MeasureBriaCell TherapeuticsIndustry median
Operating Income-$32.03M-$21.40M
Net Income-$30.68M-$22.46M
EBITDA-$32.03M-$16.91M

Returns

MeasureBriaCell TherapeuticsIndustry median
Return on Assets (ROA)-139.2%-40.9%
Return on Capital Employed (ROCE)-136.4%-38.1%

Balance sheet

MeasureBriaCell TherapeuticsIndustry median
Cash & Short-Term Investments$22.80M$61.43M
Net Cash (Debt)$22.80M$15.35M
Net Cash Per Share$2.62$0.66
Working Capital$21.80M$76.81M

Financial position

MeasureBriaCell TherapeuticsIndustry median
Current Ratio7.073.34
Quick Ratio6.352.44

Cash flow (trailing twelve months)

MeasureBriaCell TherapeuticsIndustry median
Operating Cash Flow-$30.82M-$12.35M

Efficiency

MeasureBriaCell TherapeuticsIndustry median
Profits Per Employee-$1.39M-$703.34K
Employee Count2274

Dividends and yields

MeasureBriaCell TherapeuticsIndustry median
Earnings Yield-104.3%-23.3%

Shares

MeasureBriaCell TherapeuticsIndustry median
Shares Outstanding8,699,79058,127,000
Shares Change (QoQ)0.00%0.54%
Float4,655,08049,136,700
Shares Held by Insiders46.5%11.6%
Shares Held by Institutions46.8%59.4%

Scores

MeasureBriaCell TherapeuticsIndustry median
Altman Z-Score-5.07-0.22
Piotroski F-Score34

Calculated by StockData from BriaCell Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.